Vivaldi Coelho Rogerio - Net Worth and Insider Trading

Vivaldi Coelho Rogerio Net Worth

The estimated net worth of Vivaldi Coelho Rogerio is at least $2 Million dollars as of 2024-04-26. Vivaldi Coelho Rogerio is the Chief Commercial Officer of Spark Therapeutics Inc and owns about 18,716 shares of Spark Therapeutics Inc (ONCE) stock worth over $2 Million. Vivaldi Coelho Rogerio is also the Director of Crinetics Pharmaceuticals Inc and owns about 5,000 shares of Crinetics Pharmaceuticals Inc (CRNX) stock worth over $212,350. Details can be seen in Vivaldi Coelho Rogerio's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Vivaldi Coelho Rogerio has not made any transactions after 2023-06-08 and currently still holds the listed stock(s).

Transaction Summary of Vivaldi Coelho Rogerio

To

Vivaldi Coelho Rogerio Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Vivaldi Coelho Rogerio owns 5 companies in total, including Bioverativ Inc (BIVV) , Spark Therapeutics Inc (ONCE) , and Minerva Neurosciences Inc (NERV) among others .

Click here to see the complete history of Vivaldi Coelho Rogerio’s form 4 insider trades.

Insider Ownership Summary of Vivaldi Coelho Rogerio

Ticker Comapny Transaction Date Type of Owner
BIVV Bioverativ Inc 2018-03-08 EVP & Chief Global Therapeutics
ONCE Spark Therapeutics Inc 2016-07-15 Chief Commercial Officer
NERV Minerva Neurosciences Inc 2014-06-30 director & President and CEO
CRNX Crinetics Pharmaceuticals Inc 2023-06-08 director
SGTX Sigilon Therapeutics Inc 2020-12-03 director & President and CEO

Vivaldi Coelho Rogerio Latest Holdings Summary

Vivaldi Coelho Rogerio currently owns a total of 2 stocks. Among these stocks, Vivaldi Coelho Rogerio owns 18,716 shares of Spark Therapeutics Inc (ONCE) as of July 15, 2016, with a value of $2 Million and a weighting of 90.92%. Vivaldi Coelho Rogerio also owns 5,000 shares of Crinetics Pharmaceuticals Inc (CRNX) as of June 8, 2023, with a value of $212,350 and a weighting of 9.08%.

Latest Holdings of Vivaldi Coelho Rogerio

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ONCE Spark Therapeutics Inc 2016-07-15 18,716 113.57 2,125,576
CRNX Crinetics Pharmaceuticals Inc 2023-06-08 5,000 42.47 212,350

Holding Weightings of Vivaldi Coelho Rogerio


Vivaldi Coelho Rogerio Form 4 Trading Tracker

According to the SEC Form 4 filings, Vivaldi Coelho Rogerio has made a total of 0 transactions in Spark Therapeutics Inc (ONCE) over the past 5 years. The most-recent trade in Spark Therapeutics Inc is the sale of 7,000 shares on July 15, 2016, which brought Vivaldi Coelho Rogerio around $371,210.

According to the SEC Form 4 filings, Vivaldi Coelho Rogerio has made a total of 1 transactions in Crinetics Pharmaceuticals Inc (CRNX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Crinetics Pharmaceuticals Inc is the acquisition of 5,000 shares on June 8, 2023, which cost Vivaldi Coelho Rogerio around $110,300.

Insider Trading History of Vivaldi Coelho Rogerio

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Vivaldi Coelho Rogerio Trading Performance

GuruFocus tracks the stock performance after each of Vivaldi Coelho Rogerio's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Vivaldi Coelho Rogerio is -27.28%. GuruFocus also compares Vivaldi Coelho Rogerio's trading performance to market benchmark return within the same time period. The performance of stocks bought by Vivaldi Coelho Rogerio within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Vivaldi Coelho Rogerio's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Vivaldi Coelho Rogerio

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -14.94 -27.28 51.5
Relative Return to S&P 500(%) -17.39 -31.09 44.27

Vivaldi Coelho Rogerio Ownership Network

Ownership Network List of Vivaldi Coelho Rogerio

No Data

Ownership Network Relation of Vivaldi Coelho Rogerio


Vivaldi Coelho Rogerio Owned Company Details

What does Bioverativ Inc do?

Who are the key executives at Bioverativ Inc?

Vivaldi Coelho Rogerio is the EVP & Chief Global Therapeutics of Bioverativ Inc. Other key executives at Bioverativ Inc include director & Chief Executive Officer John Cox , EVP & CFO and Treasurer John Greene , and Chief Accounting Officer Diantha Duvall .

Bioverativ Inc (BIVV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Bioverativ Inc (BIVV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Bioverativ Inc (BIVV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Bioverativ Inc (BIVV)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Bioverativ Inc Insider Transactions

No Available Data

Vivaldi Coelho Rogerio Mailing Address

Above is the net worth, insider trading, and ownership report for Vivaldi Coelho Rogerio. You might contact Vivaldi Coelho Rogerio via mailing address: 225 Second Avenue, Waltham Ma 02451.

Discussions on Vivaldi Coelho Rogerio

No discussions yet.